Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Friday 23 October, 2020

DXS International plc

Director/PDMR Shareholding

Director/PDMR Shareholding

DXS INTERNATIONAL PLC

Notification of Director / PDMR Dealing

The Board of DXS International plc (the “Company”), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems has received notification that on 22 October 2020 Mr Bob Sutcliffe, the Chairman, purchased 14,814 Ordinary Shares in the Company at a price of 6.75p per share.

Following the transaction specified above Mr Sutcliffe has a beneficial holding of 532,049 Ordinary Shares representing 1.10% of the issued share capital of the Company.

1

 
Details of the person discharging managerial responsibilities / person closely associated
a)

 
Name

 
Robert Sutcliffe

 
2 Reason for the notification
a)

 
Position/status

 
Chairman
b)

 
Initial notification /Amendment

 
Initial
3

 
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 
a)

 
Name

 

 
DXS INTERNATIONAL PLC
b)

 
LEI

 

 
2138001R1KEUWTXEVJ44
4

 
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)

 
Description of the financial instrument, type of instrument Ordinary Shares of 0.33p each
   
Identification code ISIN GB00B2Q6HZ92
   
b)

 
Nature of the transaction

 
Purchase
c)

 
Price(s) and volume(s)        
    Price(s) Volume(s)  
    6.75p 14,814  
         
d)

 
Aggregated information  
   
- Aggregated volume  
   
- Price  
   
e)

 
Date of the transaction

 

 
22 October 2020
f)

 
Place of the transaction

 

 
AQSE

The Directors of DXS International plc accept responsibility for this announcement

Enquiries:

David Immelman      (Chief Executive)
DXS International plc
01252 719800
[email protected]
Wrecclesham House
Wrecclesham Road
Farnham
Surrey
GU10 4PS
 
www.dxs-systems.co.uk  


Corporate Advisor

 
 
David Papworth
City & Merchant
0207 101 7676

 


Corporate Broker

 
 
Hybridan LLP
Claire Louise Noyce

 
020 3764 2341

 

Note to Editors:

DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively which should significantly contribute towards the NHS achieving its projected efficiency savings.


a d v e r t i s e m e n t